Azimuth Capital Management Upped Its Pfizer (PFE) Position; Credit Agricole S A Boosted Xilinx (XLNX) Holding By $539,064

July 25, 2018 - By William Brooks

Xilinx, Inc. (NASDAQ:XLNX) Logo

Azimuth Capital Management Llc increased Pfizer Inc (PFE) stake by 3.12% reported in 2018Q1 SEC filing. Azimuth Capital Management Llc acquired 17,523 shares as Pfizer Inc (PFE)’s stock declined 3.80%. The Azimuth Capital Management Llc holds 578,922 shares with $20.55 million value, up from 561,399 last quarter. Pfizer Inc now has $222.28B valuation. The stock increased 0.80% or $0.3 during the last trading session, reaching $38. About 14.50 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 10.95% since July 25, 2017 and is uptrending. It has underperformed by 1.62% the S&P500. Some Historical PFE News: 29/03/2018 – PFIZER: POSITIVE TOPLINE RESULTS FROM PHASE 3 ATTR-ACT STUDY OF; 16/04/2018 – AstraZeneca Presents lmfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting; 03/04/2018 – RPT-PFIZER IN TALKS WITH P&G ON CONSUMER BUSINESS SALE – CNBC, CITING; 03/04/2018 – PFIZER IN TALKS WITH P&G ON CONSUMER BUSINESS SALE – CNBC, CITING; 07/05/2018 – INDIA’S PFIZER LTD PFIZ.NS – MARCH QTR NET PROFIT 1.05 BLN RUPEES VS PROFIT OF 680.4 MLN RUPEES YR AGO; 25/05/2018 – LUPIN LTD LUPN.NS SAYS MARKETING AUTHORIZATION APPLICATION FOR ETANERCEPT BIOSIMILAR ACCEPTED FOR REVIEW BY EUROPEAN MEDICINES AGENCY; 17/05/2018 – Pfizer: LYRICA Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint; 26/03/2018 – Phase III IMpower150 Study Showed Genentech’s TECENTRIQ (Atezolizumab) and Avastin (Bevacizumab) Plus Carboplatin and; 03/04/2018 – PFIZER INC PFE.N SAYS ALLOGENE WILL RECEIVE RIGHTS FROM CO TO 16 PRE-CLINICAL CAR T ASSETS LICENSED FROM CELLECTIS AND SERVIER; 15/05/2018 – FDA OK’S HOSPIRA’S RETACRIT TREATMENT FOR ANEMIA

Credit Agricole S A increased Xilinx Inc (XLNX) stake by 11.02% reported in 2018Q1 SEC filing. Credit Agricole S A acquired 7,487 shares as Xilinx Inc (XLNX)’s stock declined 2.64%. The Credit Agricole S A holds 75,404 shares with $5.45 million value, up from 67,917 last quarter. Xilinx Inc now has $17.12B valuation. The stock increased 0.34% or $0.23 during the last trading session, reaching $67.97. About 1.85M shares traded. Xilinx, Inc. (NASDAQ:XLNX) has risen 6.37% since July 25, 2017 and is uptrending. It has underperformed by 6.20% the S&P500. Some Historical XLNX News: 25/04/2018 – Xilinx: 1Q Gross Margin Is Expected to Be 69% to 71%; 25/04/2018 – XILINX 4Q EPS 64C, EST. 65C; 17/04/2018 – Xilinx Closes Above 200-Day Moving Average: Technicals; 25/04/2018 – Xilinx Reports Record Annual And Quarterly Revenues; 25/04/2018 – XILINX 4Q NET REV. $672.9M, EST. $650.3M; 25/04/2018 – XILINX BOOSTS DIVIDEND; 13/03/2018 – Broadcom for Xilinx, Mellanox? Or Just More Capital Returns? — Barron’s Blog; 21/04/2018 – DJ Xilinx Inc, Inst Holders, 1Q 2018 (XLNX); 25/04/2018 – Xilinx 4Q Net $166M; 25/04/2018 – Xilinx: June Quarter Tax Rate Is Expected to Be Approximately 10% -14%

Investors sentiment decreased to 1.12 in 2018 Q1. Its down 0.09, from 1.21 in 2017Q4. It turned negative, as 45 investors sold XLNX shares while 178 reduced holdings. 67 funds opened positions while 182 raised stakes. 216.96 million shares or 2.23% less from 221.90 million shares in 2017Q4 were reported. 259,552 were reported by Friess Assoc Limited Co. Cypress Asset Mgmt Tx owns 18,282 shares. Richard Bernstein Limited Liability reported 5,804 shares or 0.01% of all its holdings. Macquarie Grp Ltd invested in 61,405 shares. Moreover, Thompson Invest Management has 0.05% invested in Xilinx, Inc. (NASDAQ:XLNX) for 3,400 shares. 6,625 are held by Northwestern Mutual Wealth Mgmt. Meiji Yasuda Asset Limited holds 0.03% or 5,061 shares in its portfolio. Nomura Asset Mgmt Ltd, Japan-based fund reported 55,545 shares. Dnb Asset Mgmt As holds 0% or 28,066 shares in its portfolio. Copeland Cap Management invested in 0.78% or 168,331 shares. Central State Bank & Communications holds 3,596 shares. Three Peaks Capital Mgmt Limited Liability Corp stated it has 12,524 shares or 0.15% of all its holdings. Palisade Cap Mngmt Ltd Nj accumulated 51,375 shares or 0.13% of the stock. Omers Administration Corp reported 79,000 shares. Mufg Americas Holdg has invested 0.17% in Xilinx, Inc. (NASDAQ:XLNX).

More news for Xilinx, Inc. (NASDAQ:XLNX) were recently published by:, which released: “Big Week Of Earnings For Chip Sector: Which Companies Are Set Up For The Biggest Moves” on July 23, 2018.‘s article titled: “Earnings Scheduled For July 25, 2018” and published on July 25, 2018 is yet another important article.

Since January 30, 2018, it had 0 buys, and 5 insider sales for $2.38 million activity. $237,615 worth of Xilinx, Inc. (NASDAQ:XLNX) was sold by Raje Salil. Madden William Christopher also sold $103,886 worth of Xilinx, Inc. (NASDAQ:XLNX) shares. On Tuesday, January 30 Hover-Smoot Scott sold $308,396 worth of Xilinx, Inc. (NASDAQ:XLNX) or 4,300 shares. 19,687 shares were sold by Tong Vincent, worth $1.45 million on Thursday, February 1.

Among 5 analysts covering Xilinx (NASDAQ:XLNX), 1 have Buy rating, 2 Sell and 2 Hold. Therefore 20% are positive. Xilinx had 7 analyst reports since April 6, 2018 according to SRatingsIntel. JP Morgan maintained Xilinx, Inc. (NASDAQ:XLNX) rating on Wednesday, May 23. JP Morgan has “Underweight” rating and $68 target. The stock has “Underweight” rating by JP Morgan on Friday, April 6. On Wednesday, May 9 the stock rating was upgraded by Nomura to “Neutral”. The company was maintained on Thursday, April 26 by KeyBanc Capital Markets. The rating was maintained by Macquarie Research with “Neutral” on Thursday, April 26. The company was maintained on Thursday, April 26 by JP Morgan. As per Friday, April 6, the company rating was downgraded by J.P. Morgan.

Credit Agricole S A decreased Abbvie Inc (NYSE:ABBV) stake by 60,504 shares to 4,193 valued at $397,000 in 2018Q1. It also reduced Raytheon Co (NYSE:RTN) stake by 25,133 shares and now owns 33,022 shares. Equity Lifestyle Pptys Inc (NYSE:ELS) was reduced too.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: which released: “Pfizer: Keep On Reinvesting Dividends” on July 24, 2018, also with their article: “Pfizer (PFE) to Build Sterile Injectable Facility in Michigan” published on July 24, 2018, published: “Major Pharma Stocks Scare Off Short Sellers” on July 25, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: and their article: “Pfizer’s Reorganizing Again. Is Its Stock a Buy Now?” published on July 16, 2018 as well as‘s news article titled: “Pfizer (PFE), GlaxoSmithKline Company ViiV Healthcare Highlights Phase III Data at AIDS 2018” with publication date: July 24, 2018.

Investors sentiment decreased to 0.89 in Q1 2018. Its down 0.17, from 1.06 in 2017Q4. It dropped, as 70 investors sold PFE shares while 718 reduced holdings. 104 funds opened positions while 595 raised stakes. 4.01 billion shares or 1.39% less from 4.07 billion shares in 2017Q4 were reported. Old Mutual Customised Solutions (Proprietary) Limited holds 0.43% or 119,530 shares. Dodge Cox holds 0.01% in Pfizer Inc. (NYSE:PFE) or 442,209 shares. Deutsche Comml Bank Ag holds 1.13% of its portfolio in Pfizer Inc. (NYSE:PFE) for 49.13 million shares. Pensionfund Dsm Netherlands holds 1.11% in Pfizer Inc. (NYSE:PFE) or 173,500 shares. Rathbone Brothers Public Limited Liability reported 0.39% of its portfolio in Pfizer Inc. (NYSE:PFE). Moreover, Cutler Inv Counsel has 0.05% invested in Pfizer Inc. (NYSE:PFE). Raymond James Financial Svcs Advsr Inc holds 0.58% or 2.85 million shares. 419,101 are held by Ledyard Bancshares. Northstar Invest Advsr Limited Liability holds 0.13% or 17,179 shares. 85,325 are held by Caprock Gp Incorporated. Stearns Financial Svcs Group has 34,134 shares. Veritas Asset Mgmt Limited Liability Partnership owns 1.41M shares. Grace And White Ny reported 11,998 shares or 0.09% of all its holdings. Meridian Invest Counsel holds 1.24% of its portfolio in Pfizer Inc. (NYSE:PFE) for 61,633 shares. Wall Street Access Asset Mgmt Limited Liability Company holds 1.29% or 26,751 shares in its portfolio.

Among 10 analysts covering Pfizer (NYSE:PFE), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Pfizer had 12 analyst reports since January 28, 2018 according to SRatingsIntel. Morgan Stanley maintained Pfizer Inc. (NYSE:PFE) rating on Wednesday, January 31. Morgan Stanley has “Overweight” rating and $43 target. The stock has “Hold” rating by Jefferies on Monday, February 26. The stock has “Hold” rating by SunTrust on Sunday, January 28. Credit Suisse maintained Pfizer Inc. (NYSE:PFE) on Wednesday, January 31 with “Neutral” rating. As per Thursday, April 5, the company rating was downgraded by Barclays Capital. As per Friday, April 13, the company rating was maintained by Jefferies. Cantor Fitzgerald initiated it with “Buy” rating and $4500 target in Thursday, June 7 report. BMO Capital Markets maintained the stock with “Outperform” rating in Wednesday, May 2 report. The rating was maintained by Leerink Swann with “Market Perform” on Wednesday, January 31.

Azimuth Capital Management Llc decreased Pepsico Inc (NYSE:PEP) stake by 24,757 shares to 216,619 valued at $23.64M in 2018Q1. It also reduced Accenture Ltd Cl A (NYSE:ACN) stake by 2,105 shares and now owns 61,957 shares. Pacwest Bancorp (NASDAQ:PACW) was reduced too.

Since February 24, 2018, it had 0 insider purchases, and 14 sales for $19.59 million activity. The insider LANKLER DOUGLAS M sold $1.84M. $1.50M worth of Pfizer Inc. (NYSE:PFE) was sold by SUSMAN SALLY on Friday, July 20. CORNWELL W DON had sold 1,758 shares worth $64,679 on Monday, February 26. Dolsten Mikael sold $2.55 million worth of Pfizer Inc. (NYSE:PFE) on Friday, March 9. 26,779 shares valued at $986,292 were sold by HILL CHARLES H on Wednesday, February 28. JOHNSON RADY A sold 27,323 shares worth $998,666. OLSON LAURIE J also sold $692,582 worth of Pfizer Inc. (NYSE:PFE) on Wednesday, June 6.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: